By Canntab Therapeutics Ltd on Tuesday, 08 October 2019
Category: Pharmaceutical - BioTech

Buds & Duds: Market conditions worsen for cannabis companies but Canntab Therapeutics soars on new joint venture agreement

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada sank 3.7% to 141.07 points. The OTCQX Cannabis Index slipped 2.6% to 515.3 points.

Buds today were Canntab Therapeutics Limited () (OTCMKTS:CTABF),  () (OTCMKTS:LXRP). The duds were  () (OTCMKTS:MMNFF),  Inc (). 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canntab Therapeutics Ltd named herein, including the promotion by the Company of Canntab Therapeutics Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Most read

Full interview: Ideanomics wins more than $7M in financing to build out its...

Ideanomics (NASDAQ: IDEX) CEO Alf Poor tells Proactive the FinTech company 's subsidiary, with projects in the electric vehicle market, has received an initial investment of $7.2 million from Qingdao Xingyang City Investment Co., Ltd. The company will headquarter its MEG subsidiary in...

11 hours, 15 minutes ago

2 min read

Related Posts